Current screening recommendations miss certain cancer predisposition syndromes, but exome sequencing can identify them.

Published Date: 19 Apr 2023

39.2 percent of people who gave their consent to whole-exome sequencing and were found to be Lynch syndrome or hereditary breast and ovarian cancer (HBOC) carriers would not have been eligible for genetic testing.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot